We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
-13.94%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$2.49B
AUM Growth
-$764M
(-24%)
Cap. Flow
-$255M
Cap. Flow
% of AUM
-10.24%
Top 10 Holdings %
Top 10 Hldgs %
45.62%
Holding
96
New
13
Increased
17
Reduced
38
Closed
17
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$46.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$45.9M |
| 3 |
Medtronic
MDT
|
+$39.2M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$37.5M |
| 5 |
EPZM
Epizyme, Inc
EPZM
|
+$33.5M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$50M |
| 2 |
BLUE
bluebird bio
BLUE
|
+$36.8M |
| 3 |
Elevance Health
ELV
|
+$32.6M |
| 4 |
Centene
CNC
|
+$32.1M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
+$31.2M |
Sector Composition
| 1 | Healthcare | 95.6% |
| 2 | Financials | 1.69% |
| 3 | Energy | 0.02% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $235M | 9.43% |
16,459,128
+552,448
| +3% | +$8.38M |
|
2
Atara Biotherapeutics
ATRA
$76.6M
| $153M | 6.17% |
176,585
+7,836
| +5% | +$7.28M |
|
3
Fate Therapeutics
FATE
$325M
| $133M | 5.35% |
10,359,666
| – | – |
|
4
Xencor
XNCR
$1.08B
| $112M | 4.49% |
3,084,703
+54,560
| +2% | +$2M |
|
5
Wave Life Sciences
WVE
$1.11B
| $94.1M | 3.78% |
2,237,607
-35,700
| -2% | -$1.59M |
|
6
argenx
ARGX
$53.7B
| $92.3M | 3.71% |
960,961
-13,545
| -1% | -$1.2M |
|
|
ALLK
7
DELISTED
Allakos
ALLK
| $88.8M | 3.57% |
1,698,648
+238,756
| +16% | +$12M |
|
|
FOLD
8
DELISTED
Amicus Therapeutics
FOLD
| $79.7M | 3.21% |
8,323,217
-79,400
| -0.9% | -$873K |
|
9
InflaRx
IFRX
$295M
| $74M | 2.98% |
2,035,400
+10,500
| +0.5% | +$323K |
|
|
CLVS
10
DELISTED
Clovis Oncology, Inc.
CLVS
| $72.9M | 2.93% |
4,060,529
+2,282,229
| +128% | +$46.6M |
|
|
WMGI
11
DELISTED
Wright Medical Group Inc
WMGI
| $69.1M | 2.78% |
2,537,300
+363,600
| +17% | +$10M |
|
|
ALDR
12
DELISTED
Alder Biopharmaceuticals
ALDR
| $66.7M | 2.68% |
6,505,766
| – | – |
|
13
Regenxbio
RGNX
$595M
| $56.8M | 2.29% |
1,354,742
-301,323
| -18% | -$17.7M |
|
14
Cigna
CI
$74.4B
| $52.3M | 2.11% |
275,610
-94,590
| -26% | -$19.7M |
|
|
IMGN
15
DELISTED
Immunogen Inc
IMGN
| $52.2M | 2.1% |
10,884,607
-1,424,428
| -12% | -$8.64M |
|
|
BOLD
16
DELISTED
Audentes Therapeutics, Inc
BOLD
| $49.1M | 1.97% |
2,301,667
+58,311
| +3% | +$1.5M |
|
17
LivaNova
LIVN
$4.52B
| $47.1M | 1.89% |
514,987
-84,301
| -14% | -$9.05M |
|
|
18
Bristol-Myers Squibb
BMY
$122B
| $44.4M | 1.79% |
+854,700
| New | +$45.9M |
|
19
eHealth
EHTH
$48.2M
| $41.9M | 1.69% |
1,091,395
-381,200
| -26% | -$12.8M |
|
20
Xeris Biopharma Holdings
XERS
$1.52B
| $41M | 1.65% |
2,412,641
+1
| +0% | +$20 |
|
|
EPZM
21
DELISTED
Epizyme, Inc
EPZM
| $40.9M | 1.64% |
6,637,278
+4,389,089
| +195% | +$33.5M |
|
22
Scholar Rock
SRRK
$6.28B
| $40.5M | 1.63% |
1,761,407
-11,700
| -0.7% | -$265K |
|
23
Tandem Diabetes Care
TNDM
$1.14B
| $39.5M | 1.59% |
1,039,750
-29,920
| -3% | -$1.06M |
|
|
24
Medtronic
MDT
$107B
| $38.2M | 1.54% |
+419,900
| New | +$39.2M |
|
25
uniQure
QURE
$2.76B
| $37.6M | 1.51% |
1,303,422
-336,478
| -21% | -$9.36M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO